Cargando…
Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy
BACKGROUND: We recently reported a randomised controlled trial on the efficacy of strength training and the β 2-adrenergic agonist albuterol in patients with facioscapulohumeral muscular dystrophy (FSHD). Strength training and albuterol appeared safe interventions with limited positive effect on mus...
Autores principales: | van der Kooi, E. L., Kalkman, J. S., Lindeman, E., Hendriks, J. C. M., van Engelen, B. G. M., Bleijenberg, G., Padberg, G. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Steinkopff-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779375/ https://www.ncbi.nlm.nih.gov/pubmed/17361345 http://dx.doi.org/10.1007/s00415-006-0432-4 |
Ejemplares similares
-
Characterizing the face in facioscapulohumeral muscular dystrophy
por: Loonen, T. G. J., et al.
Publicado: (2020) -
Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial
por: Voet, Nicoline BM, et al.
Publicado: (2010) -
Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy
por: Greco, Anna, et al.
Publicado: (2020) -
The socioeconomic burden of facioscapulohumeral muscular dystrophy
por: Blokhuis, Anna M., et al.
Publicado: (2021) -
Ophthalmological findings in facioscapulohumeral dystrophy
por: Goselink, Rianne J M, et al.
Publicado: (2019)